Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance).
      QxMD      Google Scholar   
Citation:
JNCI Cancer Spectr vol 4 (1) pkz078
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-internal-user
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
9
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
Eli Lilly and Company, Genentech, Pfizer Inc, Sanofi  
Grants:
U10CA180821, U10CA180882, U10CA180867, K99CA218603, R01CA118553, R01CA149222, R01CA169141, P50CA127003, U10CA180790, U10CA180791, U10CA180795, U10CA180799, U10CA180830, U10CA180836, U10CA180838, U10CA180850, U10CA180888 (SWOG), R25-CA203650, U54-GM104940  
Corr. Author:
 
Authors:
                                       
Networks:
CA011, CA136, CAPITAL, LAPS-CT018, LAPS-IL057, LAPS-IN007, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, NC002, OR013   
Study
Alliance-A151738
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80405
Phases:
N/A, 3
Keywords: